The education you want - wherever you want.
OnCall is a podcast series from AmerisourceBergen where we will discuss the latest industry information relevant to our GPO member practices. We will share regular updates from our knowledgeable staff and partners, as well as your respected peers, on everything from precision medicine and biosimilar innovations to practice management solutions and the legislative landscape. Listen from your computer during breaks at the office or from your phone on the go - we make it easy to fit educational content into your schedule.
Featured episodes
Buy and Bill: The Basics
In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill.
If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCallGPO@gmail.com.
Episode archives
January 2025
Buy and Bill: The Basics
In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill.
May 2024
Biosimilar Basics: Market Landscape
In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.
February 2023
GPO Legislative Townhall: Part 1
In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disparities/SDOH.
September 2022
Biosimilar Series: Part 5
In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts.
September 2022
Biosimilar Series: Part 4
In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and Medicare.
August 2022
Biosimilar Series: Part 3
In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar use.
July 2022
Biosimilar Series: Part 1
In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchangeability with their reference products, and Kathy’s experience with adopting them into her practice.
April 2022
Biomarkers: Emerging Targets and Technologies
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of emerging biomarkers to basket and umbrella trial designs.
April 2022
Biomarker Testing: A Closer Look at When, Who, and How to Test
In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and disadvantages of liquid biopsies to the benefits of ordering test panels.
March 2022
Germline Genetic Testing
In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care.
In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.
The content and information contained in this podcast is sponsored by Invitae. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of AmerisourceBergen or Invitae.
In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.
The content and information contained in this podcast is sponsored by Invitae. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of AmerisourceBergen or Invitae.
January 2022
Biomarkers 101: Basics of Biomarker Testing
In this episode, a part of our biomarker testing series, I’m joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about the basics of biomarker testing – from identifying common testing approaches to comparing DNA and RNA sequencing.
August 2021
Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML
Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD.
Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.
Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.
November 2021
Novel Agents and Toxicity Management 101
In this episode, we are joined by Dr. Ian Olver, medical oncologist, bioethicist, researcher and current Professorial Research Fellow in the School of Psychology at the University of Adelaide, to discuss strategies and tools to support community oncologists in keeping patients on effective drugs by better managing the associated toxicities.
October 2021
Using AI Clinical Decision Support to Manage Cancer Complexity
In this episode, we are joined by Dr. Fred Ashbury, co-founder and chief scientific officer at Viecure, to highlight the key areas where A.I. significantly improves your ability to treat patients effectively and efficiently while also adding value to your practice.
July 2021
Off Our Chests: A Discussion with Dr. John and Liza Marshall
In this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and his wife, Liza Marshall, to discuss their book, “Off Our Chests: A Candid Tour Through the World of Cancer”.
May 2021
Precision Medicine Evolution, Pt 2
In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for ION Solutions, discuss the advancements in liquid and tissue biopsy testing as well as the improvements our partners are making in the precision medicine space.
March 2021
Precision Medicine Evolution, Pt 1
Susan Weidner, Senior VP of IntrinsiQ Analytics, and Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, discuss the overall strategy for ION’s precision medicine program - from the creation of the Precision Medicine Advisory Panel to where we are headed in the future.
December 2020
Precision Medicine Center
Nicole Chambers, Senior Director of Corporate Services at ION Solutions, and Carol Riley, Practice Manager at St. Louis Cancer Care, will discuss the creation of the Precision Medicine Center, ION’s centralized library of Precision Medicine testing recommendations, and its regular use within the processes of one of our practices.